Combination therapy using anti-EGFR and anti-HER2 antibodies

Details for Australian Patent Application No. 2006332212 (hide)

Owner Merck Patent GmbH L'Institut National de la Sante et de la Recherche Medicale University of Montpellier 1 Centre Regional de Lutte Contre le Cancer

Inventors Gillies, Stephen D.; Azria, David; Larbouret, Christel; Pelegrin, Andre

Agent Davies Collison Cave

Pub. Number AU-A-2006332212

PCT Pub. Number WO2007/076923

Priority 06000107.0 04.01.06 EP

Filing date 15 December 2006

Wipo publication date 12 July 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/076923 Priority application(s): WO2007/076923

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332213-Radiation applicator and method of radiating tissue

2006332210-Quench system for metallurgical gases